Anónimo. Towards better patient care: drugs to avoid in 2019. Prescrire Int 2019;39:abril. [Ref.ID 103075]

Anónimo. Allopurinol + azathioprine: aplasies médullaires. Prescrire 2015;35:672. [Ref.ID 99720]

Fox C, Hull R. Many drugs used for rheumatic disease cause neutropenia. BMJ 2014;349:g6450. [Ref.ID 98357]

Hay D, Hill M, Littlewood T. Neutropenia in primary care. BMJ 2014;349:g5340. [Ref.ID 98347]

Anónimo. Gabapentine et prégabaline: une toxicité hépatique et sanguine parfois grave. Prescrire 2014;34:515-6. [Ref.ID 98076]

Fuzier R, Serres I, Guitton E, Lapeyre-Mestre M, Montastruc J-L, The French Network of Pharmacovigilance Centres. Adverse drug reactions to gabapentin and pregabalin. A review of the French Pharmacovigilance Database. Drug Saf 2013;36:55-62. [Ref.ID 94652]

Ramo Tello C. Precaucions en l'ús dels fàrmacs per a l'esclerosi múltiple. Butlletí d'Informació Terapèutica 2012;23:40-7. [Ref.ID 93279]

Anónimo. Everolimus and pazopanib: two new drugs for renal cell cancer. Med Lett Drugs Ther 2010;52:33-4. [Ref.ID 88491]

Faus Soler MT, Zaragoza Marcet A, Escobar Cava P, Tenías Burillo JM, Sangrador García G. Reacciones adversas de la terapia combinada peginterferon alfa y ribavirina en pacientes con hepatitis C crónica. Aten Farmaceutica 2009;11:110-6. [Ref.ID 86180]

Ellis P, Barrett-Lee P, Johnson L, Cameron D, Wardley A, O'Reilly S, Verrill M, Smith I, Yarnold J, Coleman R, Earl H, Canney P, Twelves C, Poole C, Bloomfield D, Hopwood P, Johnston S, Dowsett M, Bartlett JMS, Ellis I, Peckitt C, Hall E, Bliss JM, for the TACT Trial Management Group and the TACT Trialists. Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial. Lancet 2009;373:1681-92. [Ref.ID 85871]

Martin M. Unravelling the mystery of the TACT trial. Lancet 2009;373:1662-3. [Ref.ID 85866]

Hsieh MM, Everhart JE, Byrd-Holt DD, Tisdale JF, Rodgers GP. Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med 2007;146:486-92. [Ref.ID 79741]

Ibáñez Ruiz C, Albarracín Serra A. Farmacovigilancia en el CMBD. Boletín Informativo del Centro de Farmacovigilancia de la Comunidad de Madrid 2006;13:1-7. [Ref.ID 79466]

López Altimiras FX, Muñoz Rodríguez FJ, Escoté Llobet S. Leucopenia asociada al uso de risperidona: presentación de un caso y revisión de la literatura. Rev Clin Esp 2006;206:162-3. [Ref.ID 76596]

Digman C, Klein AK, Pittas AG. Leukopenia and thrombocytopenia caused by thiazolidinediones. Ann Intern Med 2005;143:465-6. [Ref.ID 75054]

Anónimo. Adalimumab: hypersensibilité et atteintes hématologiques. Prescrire 2005;25:352. [Ref.ID 73744]

Klareskog L, van der Heijde D, Fatenejad S. Etanercept and methotrexate in rheumatoid arthritis. Authors' reply. Lancet 2004;363:1733. [Ref.ID 70184]

Anónimo. Oseltamivir. Adverse reactions section to include acute renal failure, thrombocytopenia, leucopenia. Japan. WHO Pharmaceuticals Newsletter 2003;5:3. [Ref.ID 68095]

Gisbert JP, González-Guijarro L, Cara C, Pajares JM, Moreno-Otero R. Actividad de la tiopurina metiltransferasa en pacientes con hepatitis autoinmune. Med Clin (Barc) 2003;121:481-4. [Ref.ID 67844]

Anónimo. Haematologic toxicity of two glycopeptides: vancomycin and teicoplanin. WHO Pharmaceuticals Newsletter 2003;3:10. [Ref.ID 66834]